Yahoo
ASX - Delayed Quote AUD

Clover Corporation Limited (CLV.AX)

1.0000 +0.0050 (+0.50%)
At close: October 30 at 4:10:11 PM GMT+11
Chart Range Bar
Loading chart for CLV.AX
  • Previous Close 0.9950
  • Open 0.9950
  • Bid 0.9800 x --
  • Ask 1.0000 x --
  • Day's Range 0.9800 - 1.0000
  • 52 Week Range 0.6550 - 1.1650
  • Volume 101,159
  • Avg. Volume 161,913
  • Market Cap (intraday) 166.999M
  • Beta (5Y Monthly) -0.34
  • PE Ratio (TTM) 16.67
  • EPS (TTM) 0.0600
  • Earnings Date (est.) --
  • Forward Dividend & Yield 0.03 (2.50%)
  • Ex-Dividend Date Oct 20, 2026
  • 1y Target Est 1.32

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.

www.clovercorp.com.au

81

Full Time Employees

July 31

Fiscal Year Ends

Packaged Foods

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

CLV.AX
29.48%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

CLV.AX
51.54%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

CLV.AX
19.90%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

CLV.AX
31.74%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

1.17
1.32 Average
1.0000 Current
1.46 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.74%

  • Return on Assets (ttm)

    11.07%

  • Return on Equity (ttm)

    13.93%

  • Revenue (ttm)

    97.41M

  • Net Income Avi to Common (ttm)

    10.46M

  • Diluted EPS (ttm)

    0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.22M

  • Total Debt/Equity (mrq)

    1.37%

  • Levered Free Cash Flow (ttm)

    5.8M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: